Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia.

Lucena-Araujo AR, Pereira-Martins DA, Koury LC, Franca-Neto PL, Coelho-Silva JL, de Deus Wagatsuma VM, Melo RAM, Bittencourt R, Pagnano K, Pasquini R, Chiattone CS, Fagundes EM, Chauffaille ML, Schrier SL, Tallman MS, Ribeiro RC, Grimwade D, Ganser A, Löwenberg B, Lo-Coco F, Sanz MA, Berliner N, Rego EM.

Blood Adv. 2017 Sep 15;1(21):1807-1814. doi: 10.1182/bloodadvances.2017005926. eCollection 2017 Sep 26.

2.

Evaluation of criteria of manual blood smear review following automated complete blood counts in a large university hospital.

Comar SR, Malvezzi M, Pasquini R.

Rev Bras Hematol Hemoter. 2017 Oct - Dec;39(4):306-317. doi: 10.1016/j.bjhh.2017.06.007. Epub 2017 Jul 31.

3.

Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results.

Hughes TP, Leber B, Cervantes F, Spector N, Pasquini R, Clementino NCD, Schwarer AP, Dorlhiac-Llacer PE, Mahon FX, Rea D, Guerci-Bresler A, Kamel-Reid S, Bendit I, Acharya S, Glynos T, Dalal D, Branford S, Lipton JH.

Leukemia. 2017 Nov;31(11):2529-2531. doi: 10.1038/leu.2017.247. Epub 2017 Aug 3. No abstract available.

4.

Molecular response to imatinib mesylate of Brazilian patients with chronic myeloid leukemia.

Vieira-Mion AL, Pereira NF, Funke VAM, Pasquini R.

Rev Bras Hematol Hemoter. 2017 Jul - Sep;39(3):210-215. doi: 10.1016/j.bjhh.2017.04.007. Epub 2017 May 18.

5.

A strategy for molecular diagnostics of Fanconi anemia in Brazilian patients.

Pilonetto DV, Pereira NF, Bonfim CMS, Ribeiro LL, Bitencourt MA, Kerkhoven L, Floor K, Ameziane N, Joenje H, Gille JJP, Pasquini R.

Mol Genet Genomic Med. 2017 May 9;5(4):360-372. doi: 10.1002/mgg3.293. eCollection 2017 Jul.

6.

Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia.

Thakar MS, Bonfim C, Walters MC, Storb R, Pasquini R, Burroughs L, Sandmaier BM, Woolfrey A, Kiem HP.

Bone Marrow Transplant. 2017 Apr;52(4):570-573. doi: 10.1038/bmt.2016.301. Epub 2017 Jan 9.

7.

The experience of the International Consortium on Acute Promyelocytic Leukemia in monitoring minimal residual disease in acute promyelocytic leukaemia.

Lange AP, Lima AS, Lucena-Araujo AR, Jácomo RH, Melo RA, Bittencourt RI, Pasquini R, Pagnano K, Fagundes EM, Chauffaille ML, Chiattone CS, Sanz MA, Lo-Coco F, Grimwade D, Rego EM.

Br J Haematol. 2018 Mar;180(6):915-918. doi: 10.1111/bjh.14490. Epub 2016 Dec 26. No abstract available.

PMID:
28025822
8.

Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Children and Adolescents with Fanconi Anemia.

Bonfim C, Ribeiro L, Nichele S, Loth G, Bitencourt M, Koliski A, Kuwahara C, Fabro AL, Pereira NF, Pilonetto D, Thakar M, Kiem HP, Page K, Fuchs EJ, Eapen M, Pasquini R.

Biol Blood Marrow Transplant. 2017 Feb;23(2):310-317. doi: 10.1016/j.bbmt.2016.11.006. Epub 2016 Nov 7.

9.

Observational study of multiple myeloma in Latin America.

Hungria VT, Maiolino A, Martinez G, Duarte GO, Bittencourt R, Peters L, Colleoni G, Oliveira LC, Crusoé E, Coelho ÉO, Pasquini R, Magalhães SM, Nunes R, Neto JV, Faria RM, Souza M, Hamerschlak N, Flantl D, Navarro JR, Conte G, Gomez-Almaguer D, Ruiz-Argüelles G, Durie BG; International Myeloma Working Group Latin America.

Ann Hematol. 2017 Jan;96(1):65-72. doi: 10.1007/s00277-016-2866-9. Epub 2016 Nov 5.

PMID:
27815724
10.

[Use Of Hospital Services By The Immigrant Population In Umbria, Italy].

Casadei R, Angeli G, Casucci P, Minelli L, Pasquini R.

Ig Sanita Pubbl. 2016 Jan-Feb;72(1):9-25. Italian.

PMID:
27077557
11.

Long-term Survival, Organ Function, and Malignancy after Hematopoietic Stem Cell Transplantation for Fanconi Anemia.

Bonfim C, Ribeiro L, Nichele S, Bitencourt M, Loth G, Koliski A, Funke VAM, Pilonetto DV, Pereira NF, Flowers MED, Velleuer E, Dietrich R, Fasth A, Torres-Pereira CC, Pedruzzi P, Eapen M, Pasquini R.

Biol Blood Marrow Transplant. 2016 Jul;22(7):1257-1263. doi: 10.1016/j.bbmt.2016.03.007. Epub 2016 Mar 11.

12.

High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia.

Lucena-Araujo AR, Kim HT, Thomé C, Jacomo RH, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Glória AB, Chauffaille Mde L, Athayde M, Chiattone CS, Mito I, Bendlin R, Souza C, Bortolheiro C, Coelho-Silva JL, Schrier SL, Tallman MS, Grimwade D, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Sanz MA, Rego EM.

Blood. 2015 Nov 12;126(20):2302-6. doi: 10.1182/blood-2015-01-623330. Epub 2015 Oct 1.

13.

Accelerated phase chronic myeloid leukemia: evaluation of clinical criteria as predictors of survival, major cytogenetic response and progression to blast phase.

Furtado VF, Santos GR, de Carvalho DS, Staziaki PV, Pasquini R, Funke VA.

Rev Bras Hematol Hemoter. 2015 Sep-Oct;37(5):341-7. doi: 10.1016/j.bjhh.2015.07.004. Epub 2015 Jul 29.

14.

BCR-ABL mutations in chronic myeloid leukemia treated with tyrosine kinase inhibitors and impact on survival.

Pagnano KB, Bendit I, Boquimpani C, De Souza CA, Miranda EC, Zalcberg I, Larripa I, Nardinelli L, Silveira RA, Fogliatto L, Spector N, Funke V, Pasquini R, Hungria V, Chiattone CS, Clementino N, Conchon M, Moiraghi EB, Lopez JL, Pavlovsky C, Pavlovsky MA, Cervera EE, Meillon LA, Simões B, Hamerschlak N, Bozzano AH, Mayta E, Cortes J, Bengió RM; Latin American Leukemia Net (LALNET).

Cancer Invest. 2015;33(9):451-8. doi: 10.3109/07357907.2015.1065499. Epub 2015 Aug 17.

PMID:
26288116
15.

BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival.

Pagnano KB, Bendit I, Boquimpani C, De Souza CA, Miranda EC, Zalcberg I, Larripa I, Nardinelli L, Silveira RA, Fogliatto L, Spector N, Funke V, Pasquini R, Hungria V, Sérgio Chiattone C, Clementino N, Conchon M, Moiraghi EB, Lopez JL, Pavlovsky C, Pavlovsky MA, Cervera EE, Meillon LA, Simões B, Hamerschlak N, Bozzano AH, Mayta E, Cortes J, Bengió 5 On Behalf Of Latin American Leukemia Net Lalnet RM.

Cancer Invest. 2015 Aug 17. [Epub ahead of print]

PMID:
26279306
16.

The care of pregnant women and their babies: empirical data from Umbria region.

Minelli L, Pasquini R, Chiavarini M.

Ann Ig. 2015 May-Jun;27(3):539-45. doi: 10.7416/ai.2015.2045.

PMID:
26152540
17.

All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies.

Sanz MA, Montesinos P, Kim HT, Ruiz-Argüelles GJ, Undurraga MS, Uriarte MR, Martínez L, Jacomo RH, Gutiérrez-Aguirre H, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Vellenga E, Holowiecka A, González-Huerta AJ, Fernández P, De la Serna J, Brunet S, De Lisa E, González-Campos J, Ribera JM, Krsnik I, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Rego EM; IC-APL and PETHEMA and HOVON Groups.

Ann Hematol. 2015 Aug;94(8):1347-56. doi: 10.1007/s00277-015-2393-0. Epub 2015 May 15.

PMID:
25975975
18.

Publications of bone marrow transplants in Latin America. A report of the Latin American Group of Bone Marrow Transplantation.

Ruiz-Argüelles GJ, Abello-Polo V, Arrais-Rodrígues C, Bouzas LF, de Souza C, Dufort G, Gabus R, Galindo-Becerra LS, Gómez-Almaguer D, Hammerschlak N, Jaime-Fagundo JC, Jaimovich G, Karduss-Urueta AJ, Labastida-Mercado N, Nese M, Pasquini R, Seber A.

Bone Marrow Transplant. 2015 Aug;50(8):1130-1. doi: 10.1038/bmt.2015.107. Epub 2015 May 11. No abstract available.

PMID:
25961776
19.

Paroxysmal nocturnal hemoglobinuria clone in 103 Brazilian patients: diagnosis and classification.

de Azambuja AP, Malvezzi M, Bitencourt MA, Oliveira MM, Medeiros LA, Pasquini R.

Rev Bras Hematol Hemoter. 2015 Mar-Apr;37(2):90-7. doi: 10.1016/j.bjhh.2015.01.001. Epub 2015 Jan 30.

20.

Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study.

Esteves I, Bonfim C, Pasquini R, Funke V, Pereira NF, Rocha V, Novis Y, Arrais C, Colturato V, de Souza MP, Torres M, Fernandes JF, Kerbauy FR, Ribeiro AA, Santos FP, Hamerschlak N.

Bone Marrow Transplant. 2015 May;50(5):685-9. doi: 10.1038/bmt.2015.20. Epub 2015 Mar 2.

PMID:
25730184
21.

To follow or not to follow the recommendations regarding microscopic analysis of the Clinical and Laboratory Standards Institute H20-A2 to validate the criteria for blood smear review?

Comar SR, Malvezzi M, Pasquini R.

Rev Bras Hematol Hemoter. 2015 Jan-Feb;37(1):69-70. doi: 10.1016/j.bjhh.2014.11.005. Epub 2014 Nov 21. No abstract available.

22.

Autologous transplantation of bone marrow adult stem cells for the treatment of idiopathic dilated cardiomyopathy.

Westphal RJ, Bueno RR, Galvão PB, Zanis Neto J, Souza JM, Guérios ÊE, Senegaglia AC, Brofman PR, Pasquini R, Cunha CL.

Arq Bras Cardiol. 2014 Dec;103(6):521-9. doi: 10.5935/abc.20140164. Epub 2014 Nov 4. English, Portuguese.

23.

Patients' perceptions about diagnosis and treatment of chronic myeloid leukemia: a cross-sectional study among Brazilian patients.

Hamerschlak N, Souza Cd, Cornacchioni AL, Pasquini R, Tabak D, Spector N, Steagall M.

Sao Paulo Med J. 2015 Nov-Dec;133(6):471-9. doi: 10.1590/1516-3180.2014.0001306. Epub 2014 Nov 7.

24.

Autologous Transplantation of Bone Marrow Adult Stem Cells for the Treatment of Idiopathic Dilated Cardiomyopathy.

Westphal RJ, Bueno RR, Galvão PB, Zanis Neto J, Souza JM, Guérios EE, Senegaglia AC, Brofman PR, Pasquini R, Cunha CL.

Arq Bras Cardiol. 2014 Nov 4;0. pii: S0066-782X2014005040164. [Epub ahead of print] Portuguese, English.

25.
26.

Are the review criteria for automated complete blood counts of the International Society of Laboratory Hematology suitable for all hematology laboratories?

Comar SR, Malvezzi M, Pasquini R.

Rev Bras Hematol Hemoter. 2014 May-Jun;36(3):219-25. doi: 10.1016/j.bjhh.2014.03.011. Epub 2014 Apr 3.

27.

[Evaluation of the healthcare continuity quality in Umbria (Italy)].

Pasquini R, Angeli G, Duca E, Minelli L.

Ig Sanita Pubbl. 2014 Mar-Apr;70(2):171-84. Italian.

PMID:
25008223
28.

Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.

Lucena-Araujo AR, Kim HT, Jacomo RH, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Chauffaille Mde L, Chiattone CS, Lima AS, Ruiz-Argüelles G, Undurraga MS, Martinez L, Kwaan HC, Gallagher R, Niemeyer CM, Schrier SL, Tallman MS, Grimwade D, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Sanz MA, Rego EM.

Ann Hematol. 2014 Dec;93(12):2001-10. doi: 10.1007/s00277-014-2142-9. Epub 2014 Jul 2.

PMID:
24981688
29.

Deep molecular responses achieved in patients with CML-CP who are switched to nilotinib after long-term imatinib.

Hughes TP, Lipton JH, Spector N, Cervantes F, Pasquini R, Clementino NC, Dorlhiac Llacer PE, Schwarer AP, Mahon FX, Rea D, Branford S, Purkayastha D, Collins L, Szczudlo T, Leber B.

Blood. 2014 Jul 31;124(5):729-36. doi: 10.1182/blood-2013-12-544015. Epub 2014 Jun 19.

30.

Immune reconstitution in patients with Fanconi anemia after allogeneic bone marrow transplantation.

Perlingeiro Beltrame M, Malvezzi M, Bonfim C, Covas DT, Orfao A, Pasquini R.

Cytotherapy. 2014 Jul;16(7):976-89. doi: 10.1016/j.jcyt.2014.02.015. Epub 2014 May 13.

PMID:
24831839
31.

Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukaemia study.

Lucena-Araujo AR, Kim HT, Jacomo RH, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, de Lourdes Chauffaille M, Chiattone CS, Lima AS, Kwaan HC, Gallagher R, Niemeyer CM, Schrier SL, Tallman MS, Grimwade D, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Sanz MA, Rego EM.

Br J Haematol. 2014 Aug;166(4):540-9. doi: 10.1111/bjh.12921. Epub 2014 May 3.

PMID:
24796963
32.

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.

Gambacorti-Passerini C, Brümmendorf TH, Kim DW, Turkina AG, Masszi T, Assouline S, Durrant S, Kantarjian HM, Khoury HJ, Zaritskey A, Shen ZX, Jin J, Vellenga E, Pasquini R, Mathews V, Cervantes F, Besson N, Turnbull K, Leip E, Kelly V, Cortes JE.

Am J Hematol. 2014 Jul;89(7):732-42. doi: 10.1002/ajh.23728. Epub 2014 Apr 28.

33.

Quality of life of chronic myeloid leukemia patients in Brazil: ability to work as a key factor.

Hamerschlak N, de Souza C, Cornacchioni AL, Pasquini R, Tabak D, Spector N, Steagall M.

Support Care Cancer. 2014 Aug;22(8):2113-8. doi: 10.1007/s00520-014-2196-1. Epub 2014 Mar 20.

PMID:
24647489
34.

Bronchiolitis obliterans in patients undergoing allogeneic hematopoietic SCT.

Vieira AG, Funke VA, Nunes EC, Frare R, Pasquini R.

Bone Marrow Transplant. 2014 Jun;49(6):812-7. doi: 10.1038/bmt.2014.25. Epub 2014 Mar 10.

PMID:
24614836
35.

Bone mineral density, vitamin D, and nutritional status of children submitted to hematopoietic stem cell transplantation.

Campos DJ, Boguszewski CL, Funke VA, Bonfim CM, Kulak CA, Pasquini R, Borba VZ.

Nutrition. 2014 Jun;30(6):654-9. doi: 10.1016/j.nut.2013.10.014. Epub 2013 Oct 30.

PMID:
24613437
36.

Immune status of Fanconi anemia patients: decrease in T CD8 and CD56dim CD16+ NK lymphocytes.

Justo GA, Bitencourt MA, Pasquini R, Castelo-Branco MT, Almeida-Oliveira A, Diamond HR, Rumjanek VM.

Ann Hematol. 2014 May;93(5):761-7. doi: 10.1007/s00277-013-1953-4. Epub 2013 Nov 16.

PMID:
24240977
37.

Increased IL10 plasmatic levels in Fanconi anemia patients.

Justo GA, Bitencourt MA, Pasquini R, Castelo-Branco MT, Rumjanek VM.

Cytokine. 2013 Nov;64(2):486-9. doi: 10.1016/j.cyto.2013.08.004. Epub 2013 Sep 7.

PMID:
24021704
38.

Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia.

Ayas M, Saber W, Davies SM, Harris RE, Hale GA, Socie G, LeRademacher J, Thakar M, Deeg HJ, Al-Seraihy A, Battiwalla M, Camitta BM, Olsson R, Bajwa RS, Bonfim CM, Pasquini R, Macmillan ML, George B, Copelan EA, Wirk B, Al Jefri A, Fasth AL, Guinan EC, Horn BN, Lewis VA, Slavin S, Stepensky P, Bierings M, Gale RP.

J Clin Oncol. 2013 May 1;31(13):1669-76. doi: 10.1200/JCO.2012.45.9719. Epub 2013 Apr 1.

39.

[Hospital-territorial services and integration of health care: the Protected Discharge program in the Umbria Region from 2005 to 2010].

Pasquini R, Angeli G, Marzulli T, Duca E, Minelli L.

Ig Sanita Pubbl. 2013 Jan-Feb;69(1):91-103. Italian.

PMID:
23532163
40.

Early lymphocyte recovery as a predictor of outcome, including relapse, after hematopoietic stem cell transplantation.

Morando J, Fortier SC, Pasquini R, Zanis Neto J, Bonfim CM.

Rev Bras Hematol Hemoter. 2012;34(6):430-5. doi: 10.5581/1516-8484.20120108.

41.

Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL.

Rego EM, Kim HT, Ruiz-Argüelles GJ, Undurraga MS, Uriarte Mdel R, Jacomo RH, Gutiérrez-Aguirre H, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Chauffaille Mde L, Chiattone CS, Martinez L, Meillón LA, Gómez-Almaguer D, Kwaan HC, Garcés-Eisele J, Gallagher R, Niemeyer CM, Schrier SL, Tallman M, Grimwade D, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Sanz MA.

Blood. 2013 Mar 14;121(11):1935-43. doi: 10.1182/blood-2012-08-449918. Epub 2013 Jan 14.

42.

Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia.

Thakar MS, Bonfim C, Sandmaier BM, O'Donnell P, Ribeiro L, Gooley T, Deeg HJ, Flowers ME, Pasquini R, Storb R, Woolfrey AE, Kiem HP.

Pediatr Hematol Oncol. 2012 Sep;29(6):568-78. doi: 10.3109/08880018.2012.708708. Epub 2012 Jul 27.

43.

An epidemiologic survey of celiac disease in the Terni area (Umbria, Italy) in 2002-2010.

Angeli G, Pasquini R, Panella V, Pelli MA.

J Prev Med Hyg. 2012 Mar;53(1):20-3.

PMID:
22803315
44.

The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL).

Rego EM, Kim HT, Ruiz-Argüelles GJ, Uriarte Mdel R, Jacomo RH, Gutiérrez-Aguirre H, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Chauffaille Mde L, Chiattone C, Martinez L, Meillón LA, Gómez-Almaguer D, Kwaan H, Garcés-Eisele J, Gallagher R, Niemeyer CM, Lowenberg B, Ribeiro R, LoCoco F, Sanz MA.

Hematology. 2012 Apr;17 Suppl 1:S36-8. doi: 10.1179/102453312X13336169155376.

PMID:
22507775
45.

HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival.

Battiwalla M, Wang T, Carreras J, Deeg HJ, Ayas M, Bajwa RP, George B, Gupta V, Pasquini R, Schrezenmeier H, Passweg JR, Schultz KR, Eapen M.

Biol Blood Marrow Transplant. 2012 Sep;18(9):1401-6. doi: 10.1016/j.bbmt.2012.02.007. Epub 2012 Feb 28.

46.

Use of venlafaxine in psychiatric disorders and climacteric syndrome: is a therapeutic bridge?

Luisi S, Castrogiovanni A, Ciani V, Pacchierotti C, Capua AD, Pasquini R, Lazzeri L, Petraglia F.

Gynecol Endocrinol. 2012 Jan;28(1):68-71. doi: 10.3109/09513590.2011.588755. Epub 2011 Nov 16.

PMID:
22087587
47.

Hyperintense basal ganglia on MR imaging in hematopoietic stem cell transplantation recipient.

de Lima PM, Piazera FZ, Bitencourt MA, Nunes EC, Morando J, Fortier SC, Koliski A, Pasquini R, Zavala J, Teive HA.

Arq Neuropsiquiatr. 2011 Aug;69(4):724. No abstract available.

48.

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib.

Cortes JE, Kantarjian HM, Brümmendorf TH, Kim DW, Turkina AG, Shen ZX, Pasquini R, Khoury HJ, Arkin S, Volkert A, Besson N, Abbas R, Wang J, Leip E, Gambacorti-Passerini C.

Blood. 2011 Oct 27;118(17):4567-76. doi: 10.1182/blood-2011-05-355594. Epub 2011 Aug 24. Erratum in: Blood. 2013 Oct 3;122(14):2524.

49.

Current patient management of chronic myeloid leukemia in Latin America: a study by the Latin American Leukemia Net (LALNET).

Cortes J, De Souza C, Ayala-Sanchez M, Bendit I, Best-Aguilera C, Enrico A, Hamerschlak N, Pagnano K, Pasquini R, Meillon L.

Cancer. 2010 Nov 1;116(21):4991-5000. doi: 10.1002/cncr.25273.

50.

Dasatinib in imatinib-resistant or imatinib-intolerant chronic myeloid leukemia in blast phase after 2 years of follow-up in a phase 3 study: efficacy and tolerability of 140 milligrams once daily and 70 milligrams twice daily.

Saglio G, Hochhaus A, Goh YT, Masszi T, Pasquini R, Maloisel F, Erben P, Cortes J, Paquette R, Bradley-Garelik MB, Zhu C, Dombret H.

Cancer. 2010 Aug 15;116(16):3852-61. doi: 10.1002/cncr.25123.

Supplemental Content

Loading ...
Support Center